Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
Year: 2025
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-25-00481
Authors: Adrian Minson, Emma Verner, Pratyush Giri, Jason Butler, Wojt Janowski, Chan Y. Cheah, Sumita Ratnasingam, Shu Min Wong, Matthew Ku, Mark Hertzberg, Kirsten Herbert, Nada Hamad, Costas K. Yannakou, Fiona Swain, Paul Neeson, Thiago M. Steiner, Javad Saghebi, Piers Blombery, Sally M. Hunter, Molly Robertson, Lei Shong Lau, Rory Bennett, Sean Harrop, Jing Xie, John F. Seymour, Michael J. Dickinson
Institutions: The Royal Melbourne Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, Concord Repatriation General Hospital, Royal Adelaide Hospital, Royal Brisbane and Women's Hospital, Calvary Mater Newcastle Hospital, Sir Charles Gairdner Hospital, Geelong Hospital, The Alfred Hospital, St Vincent's Hospital Melbourne, Prince of Wales Hospital, Cabrini Hospital, St Vincent's Hospital Sydney, Epworth Hospital, The University of Queensland, Princess Alexandra Hospital
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411399619